Risk Stratification and Treatment Algorithm of Metastatic Renal Cell Carcinoma

Systemic therapy for metastatic renal cell carcinoma has continuously evolved over the last two decades. Significant improvements in overall survival and quality of life of patients with advanced disease have been observed. With the approval of combination therapies with PD(L)-1 immune checkpoint in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marc-Oliver Grimm, Katharina Leucht, Susan Foller
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/b7721a5e28b94164a3b0a80090376961
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!